The formulation related impact of disks on the USP XX disintegration test
Van Aerde, P.; Pimhataivoot, P.; Van Severen, R.
Journal de Pharmacie de Belgique 40(6): 395-397
1985
ISSN/ISBN: 0047-2166 PMID: 3831294 Document Number: 253561
Document emailed within 1 workday
Related Documents
Khalil, S.A.; Ali, L.M. 1972: Some formulation factors affecting disintegration and dissolution of chloramphenicol capsules Acta Pharmaceutica Suecica 9(6): 563-572Sandell, E.; Eriksson, K.; Mellström, G. 1970: A disintegration test for evaluation of drug availability from tablets and capsules Acta Pharmaceutica Suecica 7(5): 559-566
Holt, D.W.; Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Richard, F.; Kutz, K. 1995: Sandimmun neoral pharmacokinetics: impact of the new oral formulation Transplantation Proceedings 27(1): 1434-1437
Chouvenc, P.; Vessot, S.; Andrieu, J. 2006: Experimental study of the impact of annealing on ice structure and mass transfer parameters during freeze-drying of a pharmaceutical formulation PDA Journal of Pharmaceutical Science and Technology 60(2): 95-103
Mystakidou, K.; Katsouda, E.; Tsilika, E.; Smyrniotis, V.; Vassiliou, I.; Tsiatas, M.; Vlahos, L. 2006: Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment Anticancer Research 26(3b): 2325-2328
Budai, P.; Fejes, S.; Várnagy, L.; Somlyay, I.M.; Takács, I. 2001: Teratogenicity test of dimethoate containing insecticide formulation and heavy elements (Cu, Cd) in chicken embryos after administration as single compounds or in combination Mededelingen 66(2b): 885-889
2003: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects Prescrire International 12(67): 179
2002: Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation Prescrire International 11(62): 177-178
Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
2003: Paracetamol for injection: new formulation. New formulation: why so widely used? Prescrire International 12(67): 178
Leonardi, C.; Bagel, J.; Yamauchi, P.; Pariser, D.; Xu, Z.; Moller, A.; Osterdal, M.L.; Stein Gold, L. 2016: The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients with Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study Journal of Drugs in Dermatology: Jdd 15(8): 981-987
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
Jehl, F.; Klossek, J.M.; Peynegre, R.; Serrano, E.; Castillo, L.; Bobin, S.; Desprez, D.; Renault, C.; Neel, V.; Rouffiac, E.; Borie, C. 2002: Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily Presse Medicale 31(34): 1596-1603
Takeda, N.; Hamana, T.; Oka, T.; Matsuyama, N.; Hirohara, M.; Kushida, K. 2015: Case Study - A Successful Outpatient Design of Cross-Professional Pharmaceutical Cooperation in Home Health Care - Reduction of Financial and Care-Related Burden by Shifting to R-Compound Enteral Semisolid Formulation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42 Suppl. 1: 36-38
Normile, D. 1996: Impact of DNA replication errors put to the test Science 272(5263): 816-817
Scheidel, B.; Blume, H.; Walter, K.; von Nieciecki, A.; Babej-Dölle, R.M. 1993: Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation Arzneimittel-Forschung 43(11): 1211-1215
1993: The HIV test in Switzerland 1992: incidence, pertinence, impact and quality Schweizer Monatsschrift für Zahnmedizin 103(5): 675
Courcelles, R. 2004: Renforcement des capacités dans le cadre d'une étude d'impact environnemental et social relative à un projet d'aménagement hydroélectrique dans le nord du Québec, au Canada - Capacity reinforcement in the framework of social and environmental impact study related to hydropower facility in northern Quebec, Canada Liaison Energie Francophonie (62): 41-46